| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 4.57e-04 | 153 | 20 | 3 | GO:0008194 | |
| GeneOntologyMolecularFunction | UDP-galactosyltransferase activity | 4.64e-04 | 32 | 20 | 2 | GO:0035250 | |
| GeneOntologyMolecularFunction | galactosyltransferase activity | 5.56e-04 | 35 | 20 | 2 | GO:0008378 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 1.16e-03 | 211 | 20 | 3 | GO:0016758 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 2.82e-03 | 288 | 20 | 3 | GO:0016757 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 5.43e-03 | 1189 | 20 | 5 | GO:0046914 | |
| GeneOntologyMolecularFunction | zinc ion binding | 1.08e-02 | 891 | 20 | 4 | GO:0008270 | |
| GeneOntologyBiologicalProcess | sphingolipid biosynthetic process | 1.61e-04 | 117 | 19 | 3 | GO:0030148 | |
| GeneOntologyBiologicalProcess | plasma membrane phospholipid scrambling | 2.58e-04 | 26 | 19 | 2 | GO:0017121 | |
| GeneOntologyBiologicalProcess | sulfur compound metabolic process | 3.03e-04 | 365 | 19 | 4 | GO:0006790 | |
| GeneOntologyBiologicalProcess | chondroitin sulfate metabolic process | 3.22e-04 | 29 | 19 | 2 | GO:0030204 | |
| GeneOntologyBiologicalProcess | membrane lipid biosynthetic process | 3.83e-04 | 157 | 19 | 3 | GO:0046467 | |
| GeneOntologyBiologicalProcess | chondroitin sulfate proteoglycan metabolic process | 4.70e-04 | 35 | 19 | 2 | GO:0050654 | |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan biosynthetic process | 4.70e-04 | 35 | 19 | 2 | GO:0015012 | |
| GeneOntologyBiologicalProcess | sphingolipid metabolic process | 5.35e-04 | 176 | 19 | 3 | GO:0006665 | |
| GeneOntologyBiologicalProcess | sulfur compound biosynthetic process | 5.53e-04 | 178 | 19 | 3 | GO:0044272 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative metabolic process | 6.04e-04 | 1226 | 19 | 6 | GO:1901135 | |
| GeneOntologyBiologicalProcess | plasma membrane organization | 6.48e-04 | 188 | 19 | 3 | GO:0007009 | |
| GeneOntologyBiologicalProcess | fatty-acyl-CoA metabolic process | 6.77e-04 | 42 | 19 | 2 | GO:0035337 | |
| Domain | Glyco_trans_31 | 1.30e-04 | 16 | 20 | 2 | IPR002659 | |
| Domain | Galactosyl_T | 1.30e-04 | 16 | 20 | 2 | PF01762 | |
| Domain | - | 1.33e-03 | 207 | 20 | 3 | 1.25.40.10 | |
| Domain | TPR-like_helical_dom | 1.87e-03 | 233 | 20 | 3 | IPR011990 | |
| Domain | TPR_1 | 4.12e-03 | 90 | 20 | 2 | PF00515 | |
| Domain | TPR_1 | 4.12e-03 | 90 | 20 | 2 | IPR001440 | |
| Domain | TPR | 8.29e-03 | 129 | 20 | 2 | SM00028 | |
| Domain | TPR_repeat | 8.79e-03 | 133 | 20 | 2 | IPR019734 | |
| Domain | TPR-contain_dom | 1.11e-02 | 150 | 20 | 2 | IPR013026 | |
| Domain | Growth_fac_rcpt_ | 1.19e-02 | 156 | 20 | 2 | IPR009030 | |
| Domain | TPR | 1.33e-02 | 165 | 20 | 2 | PS50005 | |
| Domain | TPR_REGION | 1.33e-02 | 165 | 20 | 2 | PS50293 | |
| Pathway | WP_PROTEOGLYCAN_BIOSYNTHESIS | 1.19e-04 | 18 | 13 | 2 | M39865 | |
| Pathway | KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE | 2.52e-04 | 26 | 13 | 2 | M7330 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM | 6.31e-04 | 41 | 13 | 2 | M27257 | |
| Pathway | WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS | 6.31e-04 | 41 | 13 | 2 | M48095 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 1.09e-03 | 54 | 13 | 2 | MM14633 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 1.22e-03 | 57 | 13 | 2 | M692 | |
| Pubmed | Strain-specific modifier genes governing craniofacial phenotypes. | 2.07e-05 | 12 | 20 | 2 | 22371338 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 4.28e-05 | 1201 | 20 | 6 | 35696571 | |
| Pubmed | 1.35e-04 | 30 | 20 | 2 | 12676797 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | 2.77e-04 | 1061 | 20 | 5 | 33845483 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q26 | 3.96e-03 | 216 | 20 | 2 | chr3q26 | |
| GeneFamily | Beta 3-glycosyltransferases | 1.75e-04 | 24 | 15 | 2 | 426 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 3.99e-03 | 115 | 15 | 2 | 769 | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.74e-05 | 63 | 20 | 3 | gudmap_kidney_adult_RenMedVasc_Tie2_k1_1000 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-05 | 154 | 20 | 3 | 75eac6970259a6916fcfa6d3400509cfa2d98d9d | |
| ToppCell | COVID-19_Severe-NK_CD56bright|World / disease group, cell group and cell class | 4.55e-05 | 157 | 20 | 3 | 9dcbabb377da7e93ec9f9abf09576a92877a7e02 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_granulocytic-mast_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.72e-05 | 159 | 20 | 3 | ecd1daa33549541aee3bf4e139ab6732efc8e74c | |
| ToppCell | COVID-19_Severe-NK_CD56bright|COVID-19_Severe / disease group, cell group and cell class | 4.72e-05 | 159 | 20 | 3 | 9e2067f0d76769717f7048dab505fadd36bbb83e | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_granulocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.72e-05 | 159 | 20 | 3 | 7b6370c9567da7d40541c6e243efa704ed7e90ae | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.28e-05 | 175 | 20 | 3 | 6759d200a133034756de9cdf2d5daceca927aac9 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_LZ|normal_Lymph_Node / Location, Cell class and cell subclass | 6.61e-05 | 178 | 20 | 3 | d75057e7463558a0d3cebde3c30befbf4704dd9a | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.06e-05 | 182 | 20 | 3 | a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_bright-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.41e-05 | 185 | 20 | 3 | 3b2da51aec057b462749ae39afb8f253afcf38d5 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.53e-05 | 186 | 20 | 3 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | droplet-Lung-21m-Epithelial-alveolar_epithelial-type_II_pneumocyte|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.77e-05 | 188 | 20 | 3 | 068b761a7b6778bc6d6c776b5f09094aac87477e | |
| ToppCell | droplet-Lung-21m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.77e-05 | 188 | 20 | 3 | c95134245dab9057eb1f9b54acb371470f9c8b86 | |
| ToppCell | droplet-Lung-21m-Epithelial-alveolar_epithelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.77e-05 | 188 | 20 | 3 | 3ee321a74f04eb0982c7b4977426946b0ae6e5a9 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 7.77e-05 | 188 | 20 | 3 | 88b3415e33db81726dd29c1f50c886e057af50a0 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.77e-05 | 188 | 20 | 3 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 7.77e-05 | 188 | 20 | 3 | 1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.89e-05 | 189 | 20 | 3 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.02e-05 | 190 | 20 | 3 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.27e-05 | 192 | 20 | 3 | b73f24d1c55dfef1eb01c26da117dbf637ea080a | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.27e-05 | 192 | 20 | 3 | 39804d9ddc67c1b41887752df2503389eae44a1a | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.53e-05 | 194 | 20 | 3 | 7b2b40a56eb9c7203ca50133b2da4fd8fdd4a5cf | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.53e-05 | 194 | 20 | 3 | 6b286992d4bb56013c0ea5a7601d3476d806175a | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.66e-05 | 195 | 20 | 3 | 4658fb197657d7692ee344ae76b11b0210c418ba | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.66e-05 | 195 | 20 | 3 | 62d369a8af2b76a2553bc8ff9cb89a133b060123 | |
| ToppCell | PCW_13-14-Epithelial|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.06e-05 | 198 | 20 | 3 | 48eb6f69a464a34ab32e8d425a22b9d45ec20428 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 9.19e-05 | 199 | 20 | 3 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.19e-05 | 199 | 20 | 3 | 63c01e8961f48ed1bed4ab619cacf318cd6de7b9 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pcp2_(Purkinje_Neurons)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.25e-04 | 83 | 20 | 2 | 1ab841bab56a05dc0e7551a1408e5c5570f548e0 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pcp2_(Purkinje_Neurons)--|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.25e-04 | 83 | 20 | 2 | 7a38262bca74f0e26ac07d936753dc83fde3cb3d | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pcp2_(Purkinje_Neurons)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.25e-04 | 83 | 20 | 2 | 46de51665a1502f3132f2d56c85e8ba365431b3d | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-03 | 128 | 20 | 2 | cfc73cb803ba50a4a8709e19e70e1e399118c849 | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-pDC|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-03 | 129 | 20 | 2 | 454bae525f6db3d0dd6347d2a2c3ea9dda9cd212 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-03 | 133 | 20 | 2 | 8ff1cf0ea1fc33fe8384c0e65c1ee1853b25a2ae | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells-pDC|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-03 | 135 | 20 | 2 | 0afe232aa1a1e6c37a5b3183b67d7fa07e0ea791 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-03 | 136 | 20 | 2 | 7cd22169fb71c6caf9feb203ad98be8480a54fba | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_activate-7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.74e-03 | 139 | 20 | 2 | 693ca81f5831b63fe6148ac755631e09f67d0ebf | |
| ToppCell | COVID-19-Mast_cells-Dendritic_cells|COVID-19 / group, cell type (main and fine annotations) | 1.79e-03 | 141 | 20 | 2 | 0fc06c2325249aa4ae65c0ace1ec3f953372f2e4 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.91e-03 | 146 | 20 | 2 | 2d907e50206c4762a8baa741363bc7f0a04bd84e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.94e-03 | 147 | 20 | 2 | 48d72b6770cd029dd299676e5d83e6ac62102049 | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgG_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.07e-03 | 152 | 20 | 2 | a2ba2d95ac9010e1a62db34dcad10d004f8a90cc | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Mast_cell-Mast_cell|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-03 | 152 | 20 | 2 | 321d322d58c12fd752de4e8ea873f3f367302813 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Mast_cell|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-03 | 152 | 20 | 2 | a4d50e9af02231c5573aee905cf0905391e6da34 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-pDC|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.07e-03 | 152 | 20 | 2 | 0c6dd41142e4ca1e54ca41e05e42ed29fbf0e570 | |
| ToppCell | metastatic_Brain-Fibroblasts-Smooth_muscle_cells|Fibroblasts / Location, Cell class and cell subclass | 2.12e-03 | 154 | 20 | 2 | 423f58fc7dcef068458cbf7b4ee989e37227041e | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-03 | 154 | 20 | 2 | 89a94a36dfd3d75e411038f04adaf0bbab17db45 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Monocytes|Myeloid_cells / Location, Cell class and cell subclass | 2.15e-03 | 155 | 20 | 2 | 85eb60d285b8bfc095c341ae90c0e3b7e7dca9c1 | |
| ToppCell | tumor_Lung-B_lymphocytes-GC_B_cells_in_the_LZ|tumor_Lung / Location, Cell class and cell subclass | 2.18e-03 | 156 | 20 | 2 | b5851474ba14dd2b4867415828b52dd98ecdd6d3 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 2.18e-03 | 156 | 20 | 2 | 19472ef1642c2ad333aa3ce3675a25c6ab1d4556 | |
| ToppCell | NS-moderate-d_07-13-Myeloid-Mast_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.18e-03 | 156 | 20 | 2 | 17c38d3b03fc38cb125cf0d165b2fd694cd88edd | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.21e-03 | 157 | 20 | 2 | 4183dbed6b31ebe13ef33eb19ba6d0fb4f625953 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-03 | 158 | 20 | 2 | ee8ce3cd202807df692b28bb1a81827d49d73862 | |
| ToppCell | Control-Myeloid-Monocytes,_Macrophages-Mast-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.26e-03 | 159 | 20 | 2 | 81782e9e370558d61af5e0c760ac9759d69fb725 | |
| ToppCell | IIF-Lymphocyte-T_NK-ILC|IIF / Disease, Lineage and Cell Type | 2.26e-03 | 159 | 20 | 2 | 55e4f21548f480ca414c00cbff5ec3b13bafd271 | |
| ToppCell | 18-Airway-Epithelial-Bud_tip_progenitor|Airway / Age, Tissue, Lineage and Cell class | 2.26e-03 | 159 | 20 | 2 | e715cadff8e7d5ebe4c2198dbdfd3ca41ecb8a6a | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells-pDC|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.29e-03 | 160 | 20 | 2 | dee756a2dc9725520d439e7273c489c2284015d8 | |
| ToppCell | Leuk-UTI-Myeloid-tDC|Leuk-UTI / Disease, Lineage and Cell Type | 2.32e-03 | 161 | 20 | 2 | 51b9f60986ed2e8e2297d31c80462c3ab65a2e5e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.32e-03 | 161 | 20 | 2 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.35e-03 | 162 | 20 | 2 | 228e33678c7f963b3032a218333f206e5fff1292 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.35e-03 | 162 | 20 | 2 | 2259e9536147e9cdee772e3a30ba7d104573262c | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.35e-03 | 162 | 20 | 2 | 64353d33af0e82ebb7cf2bba74d52ca0586a58fc | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.37e-03 | 163 | 20 | 2 | 1c014e373667be290d7fb5d24c06c6f313ac8fa3 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.37e-03 | 163 | 20 | 2 | 9f5facfa1864eb63e2f8022ad7379d9252b7a254 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-ILC3|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.40e-03 | 164 | 20 | 2 | 631ec9f54475dcc9d6b1c5bf6917e7fda4671034 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-03 | 165 | 20 | 2 | 7c771f22b58989572c939ed127e637ec28dc0dca | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.43e-03 | 165 | 20 | 2 | 62457b7b74c6eae42d91d65e7dc6df6bf8e061f7 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.43e-03 | 165 | 20 | 2 | cece16b03282d27fb49102eb9c104a2024efd28c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.46e-03 | 166 | 20 | 2 | 60060b03f2abfa3cc08107ab5a9f578e60e4ae16 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.46e-03 | 166 | 20 | 2 | ec9161d388db5a257b8d125c14f9dd911d5d5d4a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.46e-03 | 166 | 20 | 2 | 4586d6725403f879fc96f67be579022587ce1906 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC1-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.46e-03 | 166 | 20 | 2 | c8a7d94ed762e5e045ab5f74eef691ddc5f74993 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.46e-03 | 166 | 20 | 2 | 89e2b8453180983533faccb4275867861876d7ee | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.49e-03 | 167 | 20 | 2 | 650de8cd5df070639b8aa292aacead739cfdb02c | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.52e-03 | 168 | 20 | 2 | 94cded2e953c0970bf2f3dbe0ce46bd77a5ed8c7 | |
| ToppCell | (3)_DC_plasmacytoid|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.52e-03 | 168 | 20 | 2 | 8a913db9b2a1a4ff96fb139734a3834e6aa263f1 | |
| ToppCell | (3)_MNP-(3)_DC_plasmacytoid|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.52e-03 | 168 | 20 | 2 | 13c160ea1a19b47d2e7e2dae818c8dcde4e3e377 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_mem-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.55e-03 | 169 | 20 | 2 | e3ec9468141b6456398dca17dd8eeaabd2462710 | |
| ToppCell | Ionocyte-iono-1|World / Class top | 2.55e-03 | 169 | 20 | 2 | 4b68bcb4b5fc3cd2db23cd4edace7444aa2d605c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-03 | 169 | 20 | 2 | 7c994653b0d629dfb046755d6b678452de0a15d2 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.58e-03 | 170 | 20 | 2 | 054360a3b05f5e41221c98b122d241b1affad26a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.58e-03 | 170 | 20 | 2 | 9ac1ef57f14418a5dd2aa16861c3df698c28f5ed | |
| ToppCell | facs-Lung-nan-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-03 | 170 | 20 | 2 | 67d7e1da3ebd2d14cb2e67799e94d655027ed5c4 | |
| ToppCell | Control-Myeloid-Mast|Control / Disease state, Lineage and Cell class | 2.58e-03 | 170 | 20 | 2 | 9a14deb7f7cd4a49c217eba4023f7bf1dec6c902 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-03 | 170 | 20 | 2 | 8e1f757ed62218c0fb6525f49d142dd2cd29acf9 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.58e-03 | 170 | 20 | 2 | 6ec0cf055ae55e9fac147f7989c47f83ab07270c | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 2.58e-03 | 170 | 20 | 2 | fbb7019c6fba87326702b51f6819ea1af5f3a9b7 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.58e-03 | 170 | 20 | 2 | f0b0d2d0402de3ed7322284a599646db43475761 | |
| ToppCell | Ionocyte|World / Class top | 2.58e-03 | 170 | 20 | 2 | d2e592f2a679e6a8d32f2b752d9a3c493e50ced4 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Lgr5+_undifferentiated_cell_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-03 | 170 | 20 | 2 | 45de83a2231208b8e1f21061d0b91644b4a3ba93 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122|Adult / Lineage, Cell type, age group and donor | 2.61e-03 | 171 | 20 | 2 | bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-03 | 171 | 20 | 2 | d9ad6a3bce3556abd24af1630bf4a99594437c3a | |
| ToppCell | Control-Myeloid-Mast|World / Disease state, Lineage and Cell class | 2.61e-03 | 171 | 20 | 2 | ed8e61d524f4cddc6084b261175df54d2a64a60f | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.61e-03 | 171 | 20 | 2 | 3d26ef58fe5231373d7df9ac79d225546918cf82 | |
| ToppCell | Healthy/Control-NK_CD56bright|World / Disease group and Cell class | 2.61e-03 | 171 | 20 | 2 | 79d7efefdae267905af05f3001514b8b6934d86e | |
| ToppCell | normal-na-Lymphocytic_NK-natural_killer_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.61e-03 | 171 | 20 | 2 | d339840626211a7bf1a9eb8f14d6c9509ab05e1c | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.61e-03 | 171 | 20 | 2 | b520d4d5620cac08315e4cbb7e796c5e9e233060 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|ILC / Donor, Lineage, Cell class and subclass (all cells) | 2.64e-03 | 172 | 20 | 2 | 4977e1f4deae781750e27a8054deccd336cfb74a | |
| ToppCell | facs-Skin-nan-24m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-03 | 172 | 20 | 2 | 5ca89af7406e7e1a055dd60d6f89615f69e62324 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.64e-03 | 172 | 20 | 2 | 6f302ed795767a9636081dc64373f8f039ea16d2 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.64e-03 | 172 | 20 | 2 | fd8097299fc05390b30afaa9e6c80b1f607c27aa | |
| ToppCell | facs-GAT-Fat-24m-Epithelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-03 | 173 | 20 | 2 | 815ba48a9222ea09ba8005e2d2f7c5addf118ad1 | |
| Disease | response to simvastatin, myopathy | 3.52e-04 | 41 | 20 | 2 | EFO_0004145, GO_1903491 | |
| Disease | hypertension, white matter hyperintensity measurement | 8.05e-04 | 62 | 20 | 2 | EFO_0000537, EFO_0005665 | |
| Disease | electroencephalogram measurement | 1.14e-03 | 74 | 20 | 2 | EFO_0004357 | |
| Disease | Disproportionate short stature | 1.24e-03 | 77 | 20 | 2 | C0878659 | |
| Disease | brain aneurysm | 2.64e-03 | 113 | 20 | 2 | EFO_0003870 | |
| Disease | C-reactive protein measurement | 7.96e-03 | 1206 | 20 | 4 | EFO_0004458 | |
| Disease | lifestyle measurement | 1.09e-02 | 235 | 20 | 2 | EFO_0010724 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CDYYLPYALGGGYVL | 206 | Q96L58 | |
| YQYPGYRGYQYLLEP | 196 | P53674 | |
| SGKYYFYDNYFDLPG | 121 | Q5TFE4 | |
| GYPLIDNYSYRGFYQ | 206 | O75752 | |
| YDIGGKYSHLPYNKY | 26 | P0C024 | |
| SLYPGYNFRYAKYYK | 286 | Q99572 | |
| YLGDFPYYYANLGLK | 461 | Q16394 | |
| NKYGEYYLLLLPGSY | 346 | P14384 | |
| SYYGLSALGPAYQKY | 186 | A1L3X0 | |
| PYLYKLYQHYYFLEG | 61 | Q6N075 | |
| GYIYFFSGPKTYKYD | 451 | O60882 | |
| NAAFLYGLGLVYFYY | 126 | O14607 | |
| PSFAYLKMGDLYYYG | 946 | Q68CR1 | |
| YLAGLLAAAYQLYYG | 271 | Q8NFT2 | |
| LDYYRKGDYVYFGLT | 151 | Q5GH73 | |
| NYLGYAVTFPYPYAK | 116 | A6NML5 | |
| GYLYIAIEYAPYGNL | 911 | P35590 | |
| IGDRLYYGEYYNAPL | 671 | Q6UWL2 | |
| GAKLQYGDPYYSYLN | 816 | Q9H9Y6 | |
| PGFKAYLDIGQVYYY | 381 | Q5TAA0 |